About this Journal Submit a Manuscript Table of Contents
ISRN Allergy
Volume 2011 (2011), Article ID 353045, 5 pages
http://dx.doi.org/10.5402/2011/353045
Clinical Study

Histamine 50-Skin-Prick Test: A Tool to Diagnose Histamine Intolerance

1Private Allergy Clinic Hall i.T., Thurnfeldgasse 3a, 6060 Hall i.T., Austria
2Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck (MUI), Schöpfstraße 41/1, 6020 Innsbruck, Austria

Received 17 December 2010; Accepted 12 January 2011

Academic Editors: N. G. Kounis and Á. Moreno-Ancillo

Copyright © 2011 Lukas Kofler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Sattler, D. Hafner, H. J. Klotter, W. Lorenz, and P. K. Wagner, “Food-induced histaminosis as an epidemiological problem: plasma histamine elevation and haemodynamic alterations after oral histamine administration and blockade of diamine oxidase (DO),” Agents and Actions, vol. 23, no. 3-4, pp. 361–365, 1988. View at Scopus
  2. L. Maintz and N. Novak, “Histamine and histamine intolerance,” American Journal of Clinical Nutrition, vol. 85, no. 5, pp. 1185–1196, 2007. View at Scopus
  3. H. G. Schwelberger, “Histamine intolerance: a metabolic disease?” Inflammation Research, vol. 59, supplement 2, pp. 219–221, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. H. G. Schwelberger and A. Falus, Eds., Histamine: Biology and Medical Aspects Karger, Springer Med Publications, Springer, New York, NY, USA, 2004.
  5. S. Schwarz, Ed., Pathophysiologie-molekulare, zelluläre, systemische Grundlagen von Krankheiten, Maudrich, Wien, Austria, 2007.
  6. C. Maslinski and W. A. Fogel, “Catabolism of histamine,” in Histamine and Histamine Antagonists, B. Uvnäs, Ed., vol. 97 of Handbook of Experimental Pharmacology, pp. 165–189, Springer, Berlin, Germany, 1991.
  7. I. Mayer, A. Missbichler, F. Wantke et al., “Optimierter radioextraktionsassay zur quantitativen bestimmung der aktivität von diaminooxidase (DAO) in humanem serum und plasma,” Allergologie, vol. 28, no. 1, pp. 1–8, 2005. View at Scopus
  8. H. Kofler, W. Aberer, M. Deibl et al., “Diamine oxidase (DAO) serum activity: not a useful marker for diagnosis of histamine intolerance,” Allergologie, vol. 32, no. 3, pp. 105–109, 2009. View at Scopus
  9. B. Töndury, B. Wüthrich, P. Schmid-Grendelmeier, B. Seifert, and B. K. Ballmer-Weber, “Histaminintoleranz: Wie sinnvoll ist die bestimmung der diaminoxidase-aktivität im serum in der alltäglichen klinischen praxis?” Allergologie, vol. 31, no. 8, pp. 350–356, 2008. View at Scopus
  10. A. Trautmann, Ed., Allergiediagnose/Allergietherapie, Georg Thieme Verlag KG, Stuttgart, Germany, 2006.
  11. F. Rueff and B. Przybilla, “Hauttests zur Diagnose von Soforttyp-Allergien. Erschienen,” in Manuale allergologicum, G. Schultz-Werninghaus, Th. Fuchs, C. Bachert, and U. Wahn, Eds., pp. 491–511, Dustri, Munchen, Germany, 2004.
  12. R. Jarisch and W. Hemmer, “Biogene Amine als Ursache von Unverträglichkeitsreaktionen. Erschienen,” in Fortschritte der praktischen Dermatologie und Venerologie, G. Plewig and H. Wolff, Eds., pp. 211–219, Springer, Berlin, Germany, 1999.
  13. R. Jarisch, Ed., Histamin-Intoleranz. Histamin und Seekrankheit, Georg Thieme Verlag KG, 2.Auflage, Stuttgart, Germany, 2004.
  14. S. Wöhrl, W. Hemmer, M. Focke, K. Rappersberger, and R. Jarisch, “Histamine intolerance-like symptoms in healthy volunteers after oral provocation with liquid histamine,” Allergy and Asthma Proceedings, vol. 25, no. 5, pp. 305–311, 2004. View at Scopus
  15. D. Francis, M. W. Greaves, and S. Yamamoto, “Enzymatic histamine degradation by human skin,” British Journal of Pharmacology, vol. 60, no. 4, pp. 583–587, 1977. View at Scopus
  16. P. Komericki, G. Klein, N. Reider et al., “Histamine intolerance: lack of reproducibility of single symptoms by oral provocation with histamine: a randomised, double-blind, placebo-controlled cross-over study,” Wiener Klinische Wochenschrift, vol. 23, no. 12, pp. S.508–510, 2010. View at Publisher · View at Google Scholar · View at PubMed
  17. N. G. Kounis, “Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm?” International Journal of Cardiology, vol. 110, no. 1, pp. 7–14, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. R. Ginsburg, M. R. Bristow, and N. Kantrowitz, “Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris,” American Heart Journal, vol. 102, no. 5, pp. 819–822, 1981. View at Scopus
  19. H. L. Haas, O. A. Sergeeva, and O. Selbach, “Histamine in the nervous system,” Physiological Reviews, vol. 88, no. 3, pp. 1183–1241, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. F. Furukawa, T. Yoshimasu, Y. Yamamoto, N. Kanazawa, and T. Tachibana, “Mast cells and histamine metabolism in skin lesions from MRL/MP-lpr/lpr mice,” Autoimmunity Reviews, vol. 8, no. 6, pp. 495–499, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. B. J. Vlieg-Boerstra, S. van der Heide, J. N. G. Oude Elberink, J. C. Kluin-Nelemans, and A. E. J. Dubois, “Mastocytosis and adverse reactions to biogenic amines and histamine-releasing foods: what is the evidence?” Netherlands Journal of Medicine, vol. 63, no. 7, pp. 244–249, 2005. View at Scopus
  22. S. M. Zimatkin and O. V. Anichtchik, “Alcohol-histamine interactions,” Alcohol and Alcoholism, vol. 34, no. 2, pp. 141–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Chrostek, B. Cylwik, and M. Szmitkowski, “Interactions between ethanol and histamineInterakcje etanolu z histamina,” Polski Merkuriusz Lekarski, vol. 23, no. 135, pp. 225–230, 2007. View at Scopus
  24. J. Sattler, R. Hesterberg, W. Lorenz, U. Schmidt, M. Crombach, and C. D. Stahlknecht, “Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side effects?” Agents and Actions, vol. 16, no. 3-4, pp. 91–94, 1985.
  25. J. Sattler and W. Lorenz, “Intestinal diamine oxidases and enteral-induced histaminosis: studies on three prognostic variables in an epidemiological model,” Journal of Neural Transmission, Supplement, vol. 32, pp. 291–314, 1990. View at Scopus
  26. J. R. Horton, K. Sawada, M. Nishibori, and X. Cheng, “Structural basis for inhibition of histamine N-methyltransferase by diverse drugs,” Journal of Molecular Biology, vol. 353, no. 2, pp. 334–344, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. J. Sattler, R. Hesterberg, U. Schmidt, M. Crombach, and W. Lorenz, “Inhibition of intestinal diamine oxidase by detergents: a problem for drug formulations with water insoluble agents applied by the intravenous route?” Agents and Actions, vol. 20, no. 3-4, pp. 270–273, 1987. View at Scopus
  28. A. Bergant, W. Lechner, E. Sölder, O. Huter, and D. Kölle, “Steigerung der uterinen Aktivität durch Histamin,” Zentralblatt für Gynakologie, vol. 115, no. 10, pp. 454–457, 1993. View at Scopus
  29. J. Petersen, A. Drasche, M. Raithel, and H. G. Schwelberger, “Analysis of genetic polymorphisms of enzymes involved in histamine metabolism,” Inflammation Research, vol. 52, no. 1, pp. S69–S70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Petersen, M. Raithel, and H. G. Schwelberger, “Characterisation of functional polymorphisms of the human diamine oxidase gene,” Inflammation Research, vol. 54, no. 1, pp. S58–S59, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus